Epigenetic regulation-mediated disorders in dopamine transporter endocytosis: A novel mechanism for the pathogenesis of Parkinson's disease
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Epigenetic mechanisms like DNA methylation and histone modifications indirectly regulate dopamine transporter (DAT) endocytosis, offering potential therapeutic targets for Parkinson
Area Of Science
- Neuroscience
- Epigenetics
- Molecular Biology
Background
- Epigenetic modifications, including DNA methylation, histone modifications, and non-coding RNA regulation, are implicated in Parkinson's Disease (PD) pathogenesis.
- These mechanisms can influence neuronal survival and dopamine transporter (DAT) endocytosis, a key process in dopamine neurotransmission.
- Dysregulation of DAT function is a hallmark of PD, making its regulation a critical therapeutic target.
Purpose Of The Study
- To explore the indirect roles of epigenetic mechanisms in regulating dopamine transporter (DAT) endocytosis.
- To identify potential therapeutic strategies for Parkinson's Disease (PD) by targeting epigenetic modulation of DAT.
- To understand how epigenetic changes influence signaling pathways and protein expression involved in DAT endocytosis.
Main Methods
- Review of existing literature on epigenetic regulation and its impact on DAT endocytosis.
- Analysis of the roles of DNA methyltransferases (DNMTs), m6A methyltransferases, and histone-modifying enzymes.
- Investigation of signaling pathways such as protein kinase C (PKC) and D2 receptor (D2R) in relation to DAT endocytosis.
Main Results
- Epigenetic enzymes like DNMTs indirectly regulate DAT endocytosis by controlling gene expression.
- RNA modifications, particularly m6A, influence protein synthesis and function involved in DAT endocytosis.
- Histone modifications alter chromatin accessibility, thereby modulating the expression of genes critical for DAT endocytosis and recycling.
Conclusions
- Epigenetic mechanisms represent a crucial, indirect control point for regulating neurotransmitter transport via DAT endocytosis.
- Targeting these epigenetic processes holds promise for developing novel therapeutic interventions for early-stage Parkinson's Disease.
- Modulating epigenetic pathways could potentially reverse cellular abnormalities and offer therapeutic benefits for PD.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
The cephalic phase is a conditioned or learned response to familiar foods. Our appetite or desire for a particular food modifies the preparatory responses directed by the brain. Individuals may produce more saliva and stomach...
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...